% Expired Patents = 50.0

EPO Patents = 2

Forward Citations = 3

Loading Chart...

7 inventors (with patents filed for the assignee):

Peter F Lenehan (3 out of 3 patents)

Thomas Stephen Everist, Iii (2 out of 2 patents)

Maria Alexandrovna Parfyonova (1 out of 1 patent)

4. Alexander Sergeevich Parfyonov (1 out of 1 patent)

5. William P Worzel (1 out of 4 patents)

6. Arpit Almal (1 out of 1 patent)

7. David W Fry (1 out of 14 patents)

8. Thomas Stephen Iii Everist (0 patent)

9. Peter F Lehehan (0 patent)

4 patents: Sort by Forward Citations

1. 10568582 - System and method for using flow-mediated dilation to provide an adjusted vascular age as an indicator of risk of cardiovascular disease (2020-02-25),

2. 10485429 - System and method of assessing endothelial function (2019-11-26),

3. 10238306 - Method for non-evasively determining an endothelial function and a device for carrying out said method (2019-03-26),

4. 9234245 - Prognostic signature for colorectal cancer recurrence (2016-01-12),

Everist Genomics, Inc. is a leading molecular diagnostics company that develops and commercializes advanced diagnostics, prognostics, and theranostics products for personalized medicine. With a focus on delivering actionable information to healthcare providers, Everist Genomics aims to improve patient outcomes and reduce healthcare costs through precision medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

4 Patents

#156 in Ann Arbor, MI

#2,020 in Michigan

#60,525 in US

Ann Arbor, MI, United States of America

Everist Genomics, Inc.